Fosinopril vs pravastatin for the prevention of cardiovascular disorders in patients with microalbuminuria

Trial Profile

Fosinopril vs pravastatin for the prevention of cardiovascular disorders in patients with microalbuminuria

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Jun 2011

At a glance

  • Drugs Fosinopril; Pravastatin
  • Indications Cardiovascular disorders
  • Focus Pharmacodynamics; Therapeutic Use
  • Acronyms PREVEND; PREVEND-IT
  • Most Recent Events

    • 01 Jun 2011 Ten-year follow-up results published in American Heart Journal.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top